Melanoma-specific cytotoxicity of a human MGSA/GRO alpha C-terminal peptide conjugated to daunorubicin

  • Authors:
    • P Roby
    • M Page
  • View Affiliations

  • Published online on: January 1, 1996     https://doi.org/10.3892/or.3.1.175
  • Pages: 175-179
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

We report the conjugation of the C-terminal alpha-helix of human melanoma growth stimulating activity to daunorubicin using the novel linker polyethylene glycol (3400) dialdehyde. The technique allows us to control the drug:peptide ratio in the conjugate. We also describe the use of capillary zone electrophoresis and HPLC to monitor both the reaction and the stability of the peptide to various pH conditions. We found that the conjugate is about 10-fold more active on human Hs294t and murine B16 melanoma eel lines (which express the MGSA receptor) than the free drug while the same conjugate has little activity on human SKOV-3 and CCL-121 non-melanoma cell lines.

Related Articles

Journal Cover

January 1996
Volume 3 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Roby P and Roby P: Melanoma-specific cytotoxicity of a human MGSA/GRO alpha C-terminal peptide conjugated to daunorubicin. Oncol Rep 3: 175-179, 1996
APA
Roby, P., & Roby, P. (1996). Melanoma-specific cytotoxicity of a human MGSA/GRO alpha C-terminal peptide conjugated to daunorubicin. Oncology Reports, 3, 175-179. https://doi.org/10.3892/or.3.1.175
MLA
Roby, P., Page, M."Melanoma-specific cytotoxicity of a human MGSA/GRO alpha C-terminal peptide conjugated to daunorubicin". Oncology Reports 3.1 (1996): 175-179.
Chicago
Roby, P., Page, M."Melanoma-specific cytotoxicity of a human MGSA/GRO alpha C-terminal peptide conjugated to daunorubicin". Oncology Reports 3, no. 1 (1996): 175-179. https://doi.org/10.3892/or.3.1.175